Are there candidates for high-dose chemotherapy in ovarian carcinoma?

BACKGROUND: Prognosis of advanced ovarian carcinomas (AOC) remains poor with a 5-year survival of 30%. Benefit from high-dose chemotherapy (HDC) in this disease has not been demonstrated to date. METHODS: To evaluate the value of HDC as consolidation treatment after surgery and platinum/taxane-based...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Sabatier, Renaud, Gonçalves, Anthony, Bertucci, François, Capiello, Maria-Antonietta, Rousseau, Frédérique, Lambaudie, Eric, Chabannon, Christian, Viens, Patrice, Extra, Jean-Marc
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2012
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3523074/
https://ncbi.nlm.nih.gov/pubmed/23072336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-31-87
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker